Iteos Therapeutics Inc (ITOS) — Long-term Investment Intensity
Iteos Therapeutics Inc (ITOS) has a Long-term Investment Intensity of 12.0% as of June 2025. Long-term investments of $74.61 Million represent 12.0% of total assets of $623.08 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of Iteos Therapeutics Inc to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Iteos Therapeutics Inc Long-term Investment Intensity (2022–2024)
This chart shows how Iteos Therapeutics Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2022 to 2024. As of June 2025, the intensity stands at 12.0%, reflecting long-term investments of $74.61 Million against total assets of $623.08 Million USD. For the complete balance sheet picture, see ITOS current and non-current assets.
Annual Long-term Investment Intensity for Iteos Therapeutics Inc (2022–2024)
The table below presents the year-by-year Long-term Investment Intensity for Iteos Therapeutics Inc from 2022 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Iteos Therapeutics Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 23.3% | $160.35 Million | $686.98 Million | ▲ +8.3 pp |
| 2023 | 15.1% | $100.54 Million | $667.59 Million | ▼ -0.6 pp |
| 2022 | 15.7% | $118.22 Million | $754.99 Million | — |